BCL9L Primary Antibody
Item Information
Catalog #
Size
Price
Description
BCL9L (B-Cell CLL/Lymphoma 9-Like) is a Protein Coding gene. Among its related pathways are Wnt Signaling Pathways: beta-Catenin-dependent Wnt Signaling and Signaling by Wnt. GO annotations related to this gene include transcription coactivator activity and beta-catenin binding. An important paralog of this gene is BCL9.
Product Overview
Entrez GenelD
283149
Aliases
BCL9-2; DLNB11
Clone#
3B9C1
Host / Isotype
Mouse / IgG1
Species Reactivity
Human
Immunogen
Purified recombinant fragment of human BCL9L (AA: 606-751) expressed in E. Coli.
Formulation
Purified antibody in PBS with 0.05% sodium azide
Storage
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Product Applications
WB (Western Blot)
1/500 - 1/2000
IHC_P(Immunohistochemistry)
1/200 - 1/1000
ELISA
1/10000
References
1.Oncotarget. 2014 Aug 30;5(16):6770-87.
2.Gastroenterology. 2011 Oct;141(4):1359-70, 1370.e1-3.
2.Gastroenterology. 2011 Oct;141(4):1359-70, 1370.e1-3.
Product Image
Elisa
Figure 1: Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Western Blot
Figure 2:Western blot analysis using BCL9L mAb against human BCL9L (AA: 606-751) recombinant protein. (Expected MW is 41.9 kDa)
Western Blot
Figure 3:Western blot analysis using BCL9L mAb against HEK293 (1) and BCL9L (AA: 606-751)-hIgGFc transfected HEK293 (2) cell lysate.
Immunohistochemical analysis
Figure 4:Immunohistochemical analysis of paraffin-embedded cervical cancer tissues using BCL9L mouse mAb with DAB staining.
For Research Use Only. Not for use in diagnostic procedures.